Amoun Pharmaceutical Company S.A.E. (“Amoun”) is an Egyptian “closed” Joint-Stock Company established in 1998 under the laws of the Arab Republic of Egypt, with a fully paid-up capital of 1.4 billion Egyptian Pounds. Amoun’s main business includes development, manufacturing, marketing, distribution, and export of a wide range of human pharmaceutical and animal health products.